Sodium cromoglycate appears to block a step in the chain of events triggered by this union. Sodium cromoglycate has no antihistaminic or anti-inflammatory activity. Continued treatment will usually keep the patient free from ophthalmic signs and symptoms during the challenge period.
Regular dosage is important.
Any remaining solution should be discarded 4 weeks after opening. Clinical experience in children under 5 years of age is limited. During clinical use, there have been, to date, no reports of adverse effects on the mother or the fetus which could be ascribed to the use of sodium cromoglycate. Nevertheless, as with all medications, caution must be exercised during pregnancy. During treatment with the sodium cromoglycate solution, soft contact lenses should not be worn.